While much evidence supports the role of IL-1 cytokines in the development of the acute and chronic phase of AD, the results targeting the pro-inflammatory cytokines such as IL-1α and IL-1β are still being investigated. The gene discussed is IL1B; the disease is Alzheimer disease.